ACIU: AC Immune SA
ACIU exchange rate has changed by -2.39% for today. During the day, the instrument was traded at a low of 2.82 and at a high of 2.94.
Follow AC Immune SA dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
ACIU News
- SMMT Stock Soars on NSCLC Drug Survival Data Beating Keytruda in China
- IONS Secures FDA Nod for Rare Brain Disorder Drug Zanvastro
- Krystal Stock Gains 13.4% in a Month: What Is Driving the Rally?
- FDA Accepts UTHR's sNDA for Tyvaso in Idiopathic Pulmonary Fibrosis
- RARE Stock Down 46% as Phase III Angelman Syndrome Study Misses Goals
- Here's Why You Should Add RNTX Stock to Your Portfolio Now
- AZN's Tagrisso Plus Orpathys Study in First-Line NSCLC Meets Goal
- KURA Stock Gains 37.6% in a Month: Here's What You Need to Know
- BNTX Ends Colorectal Cancer Immunotherapy Study, Stock Down
- LLY's Mounjaro Gets FDA Nod to Cut Cardiovascular Risk in Diabetes
- Here's Why You Should Add ARQT Stock to Your Portfolio Now
- Gilead Wins FDA Nod for Bixlenvo in Adults Living With HIV Infection
- FDA Accepts United Therapeutics' NDA Filing for Ralinepag in PAH
- AZN/AMGN's Tezspire Hits Primary Goal in Eosinophilic Esophagitis Study
- BHVN Stock Soars 18% on $795M Out-Licensing Deal for Epilepsy Program
- JAZZ Secures FDA Nod for Expanded Use of Ziihera in Gastric Cancer
- SYRE Stock Sinks After Mixed SKYWAY Study Data in Rheumatoid Arthritis
- RGNX Stock Slumps 25% on FDA Clinical Hold for RGX-121 Gene Therapy
- Here's Why You Should Add ACET Stock to Your Portfolio Now
- Acadia Gets European Commission Nod for Daybu in Rett Syndrome
- Anika Stock Gains 43.4% in the Past 3 Months: Here Is Why?
- TEVA's Ecopipam Wins FDA Priority Tag in Pediatric Tourette Syndrome
- AC Immune Says Early Data from Anti-Inflammatory Drug Gives Wider Clinical Momentum for Pipeline - AC Imm
- Reasons Why Investors Should Consider Betting on PGEN Stock
Frequently Asked Questions
What is ACIU stock price today?
AC Immune SA stock is priced at 2.86 today. It trades within 2.82 - 2.94, yesterday's close was 2.93, and trading volume reached 264. The live price chart of ACIU shows these updates.
Does AC Immune SA stock pay dividends?
AC Immune SA is currently valued at 2.86. Dividend policy depends on the company, while investors also watch -1.38% and USD. View the chart live to track ACIU movements.
How to buy ACIU stock?
You can buy AC Immune SA shares at the current price of 2.86. Orders are usually placed near 2.86 or 3.16, while 264 and -1.72% show market activity. Follow ACIU updates on the live chart today.
How to invest into ACIU stock?
Investing in AC Immune SA involves considering the yearly range 2.10 - 4.00 and current price 2.86. Many compare 9.16% and 2.14% before placing orders at 2.86 or 3.16. Explore the ACIU price chart live with daily changes.
What are AC Immune SA stock highest prices?
The highest price of AC Immune SA in the past year was 4.00. Within 2.10 - 4.00, the stock fluctuated notably, and comparing with 2.93 helps spot resistance levels. Track AC Immune SA performance using the live chart.
What are AC Immune SA stock lowest prices?
The lowest price of AC Immune SA (ACIU) over the year was 2.10. Comparing it with the current 2.86 and 2.10 - 4.00 shows potential long-term entry points. Watch ACIU moves on the chart live for more details.
When did ACIU stock split?
AC Immune SA has gone through stock splits historically. These changes are visible in , 2.93, and -1.38% after corporate actions.
- Previous Close
- 2.93
- Open
- 2.91
- Bid
- 2.86
- Ask
- 3.16
- Low
- 2.82
- High
- 2.94
- Volume
- 264
- Daily Change
- -2.39%
- Month Change
- 9.16%
- 6 Months Change
- 2.14%
- Year Change
- -1.38%